SCHEMBL6160635

SCHEMBL6160635

Cc1cccc(CNC(=O)c2c[nH]c3c(c2=O)CCCC3)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MMP13 P45452 1/20 0.46
BACE1 P56817 2/20 0.45
MAPT P10636 3/20 0.45
POLB P06746 4/20 0.44
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 2/20 0.44
ESR1 P03372 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
THRB P10828 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
WDR5 P61964 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161603 0.88 GABRP (0.47) ALDH1A1HPGDBACE1POLBADORA2A
SCHEMBL6161991 0.88 ADORA2A (0.57) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL6161872 0.87 GABRP (0.47) ADORA2AADORA1RAB9ANPC1SMN1; SMN2
SCHEMBL6162309 0.87 LMNA (0.53) ALDH1A1HPGDBACE1MAPTPOLB
SCHEMBL6161545 0.86 NPC1 (0.61) KDM4EALDH1A1HPGDMMP13POLB
SCHEMBL6162507 0.86 ADORA2A (0.55) ALDH1A1HPGDPOLBADORA2AADORA1
SCHEMBL6162671 0.85 HPGD (0.55) ALDH1A1HPGDPOLBADORA2AADORA1
SCHEMBL6163180 0.84 NPC1 (0.58) KDM4EALDH1A1HPGDMMP13BACE1
SCHEMBL6160996 0.84 ADORA2A (0.55) ALDH1A1HPGDPOLBADORA2AADORA1
SCHEMBL6160803 0.81 ADORA2A (0.55) ALDH1A1MAPTPOLBADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
EP-1056724-A2 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 2000-12-06 EP claimed
WO-1999043661-A2 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1999-09-02 WO claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed